금 나노입자 시장 규모, 점유율, 동향 및 예측 : 유형, 용도, 최종 용도 산업, 지역별(2026-2034년)

The global gold nanoparticles market size was valued at USD 6.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 14.4 Billion by 2034, exhibiting a CAGR of 9.27% during 2026-2034. North America currently dominates the market, holding a significant market share of over 31.4% in 2025. This dominance can be attributed to the region's advanced healthcare infrastructure, strong presence of nanotechnology firms, and high investment in research and development. Favorable regulatory frameworks and growing applications in diagnostics and drug delivery further contribute to North America's leading position in gold nanoparticle market share.

The market is being driven by their expanding role in precision medicine, particularly in cancer theranostics and photothermal therapy. Growing demand for targeted drug delivery systems and the superior surface functionalization properties of gold nanoparticles are encouraging their integration in biomedical applications. Additionally, rising investments in nanotechnology-based research and academic collaborations are facilitating rapid innovation across sectors. For instance, in February 2024, researchers at Goa University developed a pioneering eco-friendly method to synthesize gold nanoparticles using indigenous Termitomyces mushrooms found on termite mounds. This innovative process replaces toxic chemicals with edible fungal biomass, creating a clean, green production route. The technique offers India the potential to reduce reliance on imports and build a local gold nanoparticle supply chain valued at approximately USD 450 Million globally. The electronics industry is also adopting gold nanoparticles for conductive inks and nanoscale circuit fabrication. Environmental sensing technologies and catalytic converters benefit from their stability and reactivity, further diversifying usage. Increasing patent activity and supportive international funding are collectively accelerating the commercialization of gold nanoparticle-based products across multiple industries.

In the United States, the gold nanoparticles market growth is propelled by a robust ecosystem of biotech startups, academic research institutions, and federal research funding, particularly from the NIH and NSF. The country's early adoption of advanced diagnostic tools and nanomedicine accelerates the use of gold nanoparticles in molecular imaging and biosensors. The strong intellectual property framework enhances investor confidence, fostering commercialization efforts. Moreover, the U.S. Department of Defense's interest in nanomaterials for medical and detection purposes contributes to demand. Domestic semiconductor and electronics industries increasingly leverage gold nanoparticles for miniaturized and high-performance components. These factors collectively contribute to the United States' prominent role in shaping the global gold nanoparticles market landscape.

GOLD NANOPARTICLES MARKET TRENDS:

Rising Medical Applications

Extensive investments in nanotechnology for cancer therapy, diagnostic imaging, and targeted drug delivery are stimulating the market across the globe. For instance, in November 2023, a review published by researchers in the Journal of Nanobiotechnology showcased existing data on nanotechnology-based delivery of active components of traditional Chinese medicines (TCMs). They described the emergence of inorganic nanocarriers, such as gold nanoparticles (Au NPs), for drug delivery, owing to their large surface area, customizable size, surface charge, etc. A recent report projects the global nanomedicine market will soar from USD 265.9 Billion in 2025 to USD 632.1 Billion by 2034, posting a robust 10.1 % CAGR, reflecting growing demand for nanoscale drug-delivery vehicles and imaging agents. Additionally, an article generated by ScienceDirect in January 2024 highlighted the evaluation of gold nanoparticles (AuNPs) that were synthesized utilizing environmentally friendly methods for their potential as multipurpose theragnostic agents in cancer treatment. The primary focus of this research reported recent breakthroughs in the production of AuNPs by adopting green nanotechnology techniques. Moreover, the unique properties of these particles make them suitable for targeted drug delivery due to their unique optical and chemical properties. This, in turn, is escalating the gold nanoparticles market demand. For instance, in October 2023, mechanical engineering doctoral student Hanwen Fan, as well as research associates Dr. Xiaoqian Ge, and Dr. Zhenpeng Qin, developed a method by utilizing gold nanoparticles designed to deliver medication through the blood-brain barrier. Furthermore, the researchers demonstrated the method for treating glioblastoma, the most common human brain cancer. Apart from it, in September 2023, researchers at the Indian Institute of Science (IISc) introduced an innovative method aimed at detecting and destroying cancer cells, particularly those forming solid tumors. As detailed in a study published in "ACS Applied Nano Materials," they developed hybrid nanoparticles composed of copper sulfide and gold. These nanoparticles have the ability to eliminate cancer cells through heat generation and facilitate their detection via sound waves.

Growing Demand for Advanced Electronics

The increasing trend of miniaturization of electronic devices is elevating the adoption of these particles, on account of their excellent conductivity and stability, which is acting as a significant growth-inducing factor. For instance, in January 2024, a research group at Pohang University of Science and Technology (POSTECH) developed a solution-based 3D printing technique to produce metamaterials affordably in customized shapes. Using this approach, the team fabricated freeform, freestanding raspberry-like metamolecule (RMM) fibers by integrating the evaporative co-assembly of gold and silica nanoparticles with 3D nanoprinting technology. Moreover, these particles find extensive applications in the manufacturing of photo-sensors and thin-film transistors, which is positively creating the gold nanoparticles market outlook. In May 2024, a study in the National Science Review showcased the dynamic and reversible optical modulation of surface plasmons. The research combines the optoelectronic manipulation of semiconductors that can be achieved by optically stimulating the hot electrons, which, in turn, modifies the conductivity of the nanogaps and the charge density in gold. Consequently, it offers a significant optoelectronic switch prototype for use in nanophotonic processors. The Semiconductor Industry Association notes that over USD 540 Billion in U.S. semiconductor-supply-chain investments are now in motion, a surge that is intensifying R&D into nanoparticle-enabled interconnects, sensors, and metamaterials.

Safety and Regulatory Considerations

Government bodies are focusing on implementing stringent regulations, owing to the widespread applications of these particles in several industries, especially in healthcare and consumer products. The National Institute of Standards and Technology (NIST) across the United States issues reference standards for nanoscale particles targeted for the biomedical research community. Additionally, regulatory authorities, such as the European Medicines Agency (EMA) in Europe and the FDA in the United States, are actively working to establish guidelines and standards for the safe use of gold nanoparticles. Additionally, many nanoscale materials are regarded as "chemical substances" under the Toxic Substances Control Act (TSCA). Consequently, the Environmental Protection Agency (EPA) issued a rule requiring one-time reporting and recordkeeping of existing exposure and health and safety information on nanoscale chemical substances. Apart from this, the rising number of comprehensive safety assessments that are conducted during the development and approval process of products containing gold nanoparticles is also elevating the gold nanoparticles market revenue. For instance, in July 2023, the FDA approved a new diagnostic tool utilizing gold nanoparticles for enhanced imaging, contingent upon rigorous preclinical and clinical testing to ensure its efficacy and safety. Furthermore, in January 2024, a new European directive was introduced that mandates traceability and labeling of nanomaterials in consumer products aimed at increasing transparency and consumer safety.

GOLD NANOPARTICLES INDUSTRY SEGMENTATION:

Analysis by Type:

• Water Soluble
• Oil Soluble
• Others

Water soluble stand as the largest type in 2025, holding around 44.6% of the market. The water-soluble segment dominates the gold nanoparticles market due to its superior biocompatibility, stability, and versatility in biomedical applications. Water-soluble gold nanoparticles easily disperse in physiological environments, making them ideal for drug delivery, imaging, and therapeutic interventions. Their ability to be functionalized with various biomolecules enhances targeting efficiency in diagnostics and treatment. Moreover, their low toxicity and ease of synthesis in aqueous media support their widespread use in academic and clinical research. As healthcare and life sciences increasingly rely on nanotechnology for non-invasive procedures, the demand for water-soluble formulations continues to rise, solidifying their dominant position in the gold nanoparticles market.

Analysis by Application:

• Imaging
• Targeted Drug Delivery
• Sensors
• In Vitro Diagnostics
• Probes
• Catalysis
• Others

Imaging leads the market with around 21.1% of market share in 2025. The imaging segment dominates the gold nanoparticles market due to the exceptional optical and electronic properties of gold nanoparticles, which enable highly sensitive and precise imaging techniques. Their strong surface plasmon resonance enhances contrast in imaging modalities such as computed tomography (CT), photoacoustic imaging, and optical coherence tomography. Gold nanoparticles can also be engineered to target specific cells or tissues, improving diagnostic accuracy in oncology and cardiovascular research. Their stability, biocompatibility, and ease of surface modification make them ideal agents for non-invasive and real-time imaging. This broad applicability and performance advantage drive the segment's leading position in the gold nanoparticles market.

Analysis by End-Use Industry:

• Electronics
• Healthcare
• Chemicals
• Others

Healthcare leads the market with around 49.1% of market share in 2025. The healthcare segment dominates the gold nanoparticles market due to their growing use in diagnostics, targeted drug delivery, and therapeutic applications. Gold nanoparticles offer excellent biocompatibility, tunable surface chemistry, and enhanced permeability, making them ideal for biomedical use. In diagnostics, they are utilized in assays, biosensors, and imaging agents to improve detection sensitivity and speed. In therapeutics, they enable precise drug delivery and photothermal therapies for cancer treatment, minimizing side effects. Continuous advancements in nanomedicine and increased R&D investments by pharmaceutical companies and academic institutions have further accelerated their adoption. These advantages firmly establish healthcare as the leading end-use sector in the gold nanoparticles market.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2025, North America accounted for the largest market share of over 31.4%. North America dominates the gold nanoparticles market due to its strong research infrastructure, high healthcare expenditure, and early adoption of advanced nanotechnology across medical and industrial sectors. The region is home to leading biotechnology and pharmaceutical companies actively investing in nanomedicine development. Robust funding from both government agencies and private institutions supports innovation in drug delivery, diagnostics, and imaging technologies. Additionally, regulatory clarity and a well-established intellectual property framework encourage commercialization of gold nanoparticle-based applications. The presence of key market players, strong academic collaborations, and a growing demand for precision medicine further reinforce North America's leading position in the global gold nanoparticles market. For instance, in March 2024, the Wiess School of Natural Sciences at Rice University, United States, introduced the Center for Nanoscale Imaging Sciences to improve the capture, analysis, and interpretation of images at the nanometer scale, contributing to breakthroughs in fields, such as materials science, biology, nanotechnology, and biomedicine.

KEY REGIONAL TAKEAWAYS:

UNITED STATES GOLD NANOPARTICLES MARKET ANALYSIS

In 2025, the United States held a market share of around 88.70% in North America. The United States gold nanoparticles market is witnessing robust growth due to rising applications in precision medicine and diagnostics. The increasing focus on personalized healthcare and targeted drug delivery systems is propelling the demand for gold nanoparticles, especially in oncological research. This funding is significantly enhancing nanotech research capabilities across academia and industry. Furthermore, expanding government and private investments in nanotechnology-based innovations are supporting the development of novel therapeutic and imaging solutions. As reported, the US federal authorities have provided more than USD1.4 Billion funding for the National Nanotechnology Initiative, which confirms the importance of nanotechnology. Academic collaborations and public-private partnerships are accelerating the integration of gold nanoparticles into next-generation biosensors and theranostics. In addition, the increasing utilization of gold nanostructures in catalysis for environmental remediation and chemical synthesis is widening the application base. The region's advanced research infrastructure and favorable regulatory frameworks are enabling faster commercialization of nanomaterials across pharmaceutical and biomedical sectors. With the rising adoption of food safety testing and advanced material coatings, the market continues to diversify.

EUROPE GOLD NANOPARTICLES MARKET ANALYSIS

The Europe gold nanoparticles market is expanding steadily, driven by increasing emphasis on sustainable nanomaterials in industrial and energy-related applications. Rising interest in green chemistry and cleaner synthesis techniques is contributing to the adoption of gold nanoparticles in catalytic converters, solar cells, and fuel cell technologies. According to the European Union Observatory for Nanomaterials (EUON), around 1.5% of all new cosmetic products notified in Europe contain nanomaterials, reflecting a growing trend toward incorporating nanoscale ingredients in consumer products. Additionally, the push for sustainable electronics and miniaturized components in consumer devices is supporting the use of gold nanoparticles in conductive inks and microelectronic circuits. Academic research in photothermal therapy and nano-optics is also encouraging interdisciplinary utilization. Growth is further reinforced by government funding initiatives focused on environmentally responsible nanotechnology. The integration of gold nanoparticles into bioimaging and biosensing devices for public health applications, including virus detection, adds to the region's innovation landscape.

ASIA PACIFIC GOLD NANOPARTICLES MARKET ANALYSIS

In the Asia Pacific region, the gold nanoparticles market is growing rapidly due to increasing investments in advanced healthcare infrastructure and expanding R&D capabilities. The region's booming electronics manufacturing industry is utilizing gold nanoparticles in flexible electronics and chip-level sensors. According to Invest India, the country's semiconductor sector, valued at USD 23.2 Billion, is projected to grow at a 17.1% CAGR to reach USD 80.3 Billion by 2028, an expansion that is expected to further stimulate demand for nanoscale materials such as gold nanoparticles. In addition, the rising demand for functional cosmetics and dermatological products is driving the use of gold nanomaterials in skincare formulations due to their anti-inflammatory and penetration-enhancing properties. Educational institutions and emerging research hubs contribute significantly to nanoparticle-based product innovation across multiple sectors. With a growing focus on agricultural nanotechnology, gold nanoparticles are being explored for precision farming and pathogen detection in crops.

LATIN AMERICA GOLD NANOPARTICLES MARKET ANALYSIS

The Latin American gold nanoparticles market is gaining momentum, driven by increasing exploration of nanotechnology in environmental monitoring and water purification systems. Research initiatives focused on developing cost-effective sensing platforms for pollutants are fostering demand for gold-based nanostructures. In line with this, upcoming water and sewage auctions in Brazil, scheduled for 2025, could unlock an estimated USD 13 Billion in new investments across 13 states, according to ABCON and BNDES, which boosts nanotech-based water treatment applications. Additionally, there is a rising interest in nano-enabled antimicrobial coatings for public infrastructure and packaging solutions. Academic institutions are actively exploring nanobiotechnology for applications in agriculture and food safety. Growing awareness of nanomaterial benefits in small-scale diagnostics and chemical detection is also encouraging regional uptake.

MIDDLE EAST AND AFRICA GOLD NANOPARTICLES MARKET ANALYSIS

The gold nanoparticles market in the Middle East and Africa is gradually expanding, supported by increasing investments in advanced medical diagnostics and sensor technologies. The integration of nanomaterials into point-of-care testing and portable biosensors is particularly gaining traction. According to IMARC Group, the diagnostic testing market in Saudi Arabia reached USD 1.83 Billion in 2024 and is projected to grow at a CAGR of 4.30% to reach USD 2.79 Billion by 2033, which is expected to further support the integration of gold nanoparticles into diagnostic solutions. There is also a growing emphasis on utilizing gold nanoparticles in photothermal-based treatments and advanced wound care systems. Nanotechnology's growing interest in desalination and clean water initiatives is accelerating the development of gold nanoparticle applications, with technology incubators and academic-led pilot projects accelerating the process.

COMPETITIVE LANDSCAPE:

The competitive landscape of the gold nanoparticles market is characterized by rapid innovation, strategic collaborations, and increasing R&D investments aimed at enhancing product performance and expanding application areas. Market participants are focusing on developing highly functional, biocompatible nanoparticles for use in diagnostics, targeted drug delivery, and imaging. Companies are also investing in scalable and cost-effective synthesis techniques to meet the rising demand across medical and electronics sectors. Regulatory compliance, technological differentiation, and customization capabilities are key competitive factors. The industry also sees frequent academic-industrial partnerships to accelerate innovation. For instance, in July 2025, Merck acquired UK-based Verona Pharma for approximately $10 Billion, enhancing its respiratory treatment portfolio. The move comes as Merck prepares for the upcoming patent expiration of its blockbuster cancer drug, aiming to diversify and strengthen its pipeline. With ongoing advancements and increasing demand for precision healthcare solutions, the gold nanoparticles market forecast projects sustained growth and intensifying competition among global and regional manufacturers over the coming years.

The report provides a comprehensive analysis of the competitive landscape in the gold nanoparticles market with detailed profiles of all major companies, including:

• BBI Solutions
• Cytodiagnostics Inc
• Meliorum Technologies, Inc.
• Nanocomposix
• NanoHybrids
• Nanopartz Inc.
• Sigma-Aldrich (Merck KGaA)
• Sona Nanotech.
• Strem Chemicals, Inc. (Ascensus Specialties)

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Gold Nanoparticles Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Water Soluble
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Oil Soluble
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Imaging
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Targeted Drug Delivery
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Sensors
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 In Vitro Diagnostics
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Probes
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Catalysis
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Others
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by End-Use Industry

• 8.1 Electronics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Healthcare
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Chemicals
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 BBI Solutions
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Cytodiagnostics Inc
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Meliorum Technologies, Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Nanocomposix
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 NanoHybrids
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Nanopartz Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Sigma-Aldrich (Merck KGaA)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Sona Nanotech.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Strem Chemicals, Inc. (Ascensus Specialties)
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis